| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Susanne Müller | Q41781636 |
| Peter J. Brown | Q42713845 | ||
| P2093 | author name string | Suzanne Ackloo | |
| P2860 | cites work | Inactivation of BRD7 results in impaired cognitive behavior and reduced synaptic plasticity of the medial prefrontal cortex. | Q47739388 |
| Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis. | Q51113215 | ||
| Decreased beige adipocyte number and mitochondrial respiration coincide with increased histone methyl transferase (G9a) and reduced FGF21 gene expression in Sprague-Dawley rats fed prenatal low protein and postnatal high-fat diets. | Q51529044 | ||
| Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis. | Q51539245 | ||
| Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery | Q54932292 | ||
| Kruidenier et al. reply | Q57808504 | ||
| Upregulated Protein Arginine Methyltransferase 1 by IL-4 Increases Eotaxin-1 Expression in Airway Epithelial Cells and Participates in Antigen-Induced Pulmonary Inflammation in Rats | Q58809184 | ||
| Requirement for therapeutic inhibition of sickle haemoglobin gelation | Q59097165 | ||
| Adverse Epigenetic Signatures by Histone Methyltransferase Set7 Contribute to Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus | Q61865854 | ||
| Getting pharmaceutical R&D back on target | Q84133263 | ||
| The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation | Q87052540 | ||
| Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA | Q24293271 | ||
| Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting | Q24308867 | ||
| Histone recognition and large-scale structural analysis of the human bromodomain family | Q24310431 | ||
| Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling | Q24312041 | ||
| A miR-19 regulon that controls NF-κB signaling | Q24602478 | ||
| Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss | Q24630545 | ||
| A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells | Q24635322 | ||
| Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region | Q24672150 | ||
| Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors | Q26744268 | ||
| The Role of Protein Arginine Methyltransferases in Inflammatory Responses | Q26752985 | ||
| Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy | Q26769943 | ||
| Histone demethylases in chromatin biology and beyond | Q26777269 | ||
| Open access chemical probes for epigenetic targets | Q26781872 | ||
| Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes | Q26996631 | ||
| Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. | Q27301265 | ||
| Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease | Q27333599 | ||
| Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition | Q27644651 | ||
| Suppression of inflammation by a synthetic histone mimic | Q27665789 | ||
| A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response | Q27670940 | ||
| Potent inhibition of DOT1L as treatment of MLL-fusion leukemia | Q27678800 | ||
| Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition | Q27700161 | ||
| A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications | Q27702140 | ||
| A Chemical Probe for the ATAD2 Bromodomain | Q27727700 | ||
| Histone methylation modifiers in cellular signaling pathways | Q28082123 | ||
| Roles of protein arginine methyltransferases in the control of glucose metabolism | Q28087448 | ||
| Targeting bromodomains: epigenetic readers of lysine acetylation | Q28238635 | ||
| The mechanisms behind the therapeutic activity of BET bromodomain inhibition | Q28241504 | ||
| Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery | Q28260105 | ||
| Targeting BET bromodomains for cancer treatment | Q28263519 | ||
| Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4 | Q28267929 | ||
| Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice | Q28300013 | ||
| Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication | Q28485063 | ||
| BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane | Q28535279 | ||
| Phosphorylation of HPV-16 E2 at serine 243 enables binding to Brd4 and mitotic chromosomes | Q28544058 | ||
| Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation | Q28546901 | ||
| An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression | Q28546918 | ||
| PRMT5-Mediated Methylation of NF-κB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-α and IFN-γ Costimulation | Q28550383 | ||
| Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo | Q28585441 | ||
| BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models | Q28828457 | ||
| DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation | Q28830958 | ||
| The unfolded protein response in immunity and inflammation | Q29248713 | ||
| Unravelling the pathogenesis of inflammatory bowel disease | Q29547551 | ||
| A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells | Q29614565 | ||
| Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila | Q29616737 | ||
| Selective inhibition of tumor oncogenes by disruption of super-enhancers | Q29617301 | ||
| Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. | Q30370542 | ||
| Targeting the Bromome: are we there yet? | Q30489777 | ||
| Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase | Q33272939 | ||
| The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study. | Q33589699 | ||
| Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. | Q33591456 | ||
| EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion | Q35758563 | ||
| The TrxG Complex Mediates Cytokine Induced De Novo Enhancer Formation in Islets | Q35822529 | ||
| The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease | Q35860836 | ||
| Recent Progress in Histone Demethylase Inhibitors | Q35879610 | ||
| Barrier-to-Autointegration Factor influences specific histone modifications | Q35883260 | ||
| Inhibition of KDM6 activity during murine ESC differentiation induces DNA damage | Q35892322 | ||
| Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection | Q35895721 | ||
| Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping | Q35904956 | ||
| H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells | Q35914266 | ||
| Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells | Q35915213 | ||
| Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS. | Q35928701 | ||
| Brd4 bridges the transcriptional regulators, Aire and P-TEFb, to promote elongation of peripheral-tissue antigen transcripts in thymic stromal cells | Q35961245 | ||
| Epstein-Barr virus oncoprotein super-enhancers control B cell growth | Q35963272 | ||
| BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell | Q35967957 | ||
| CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses | Q36008355 | ||
| Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions | Q36030989 | ||
| EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression. | Q36169265 | ||
| BET bromodomain inhibitors--a novel epigenetic approach in castration-resistant prostate cancer | Q36211507 | ||
| PRMT1 and PRMT4 Regulate Oxidative Stress-Induced Retinal Pigment Epithelial Cell Damage in SIRT1-Dependent and SIRT1-Independent Manners. | Q36259933 | ||
| Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy | Q36301666 | ||
| Epigenetic regulation of MHC-II and CIITA genes | Q36548065 | ||
| BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice | Q36575895 | ||
| The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies | Q36584337 | ||
| Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy | Q36656799 | ||
| A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases | Q36703511 | ||
| BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. | Q36718203 | ||
| Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. | Q36781887 | ||
| The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb | Q36790027 | ||
| Asymmetric arginine dimethylation of RelA provides a repressive mark to modulate TNFα/NF-κB response | Q36831485 | ||
| Proteomic dissection of LPS-inducible, PHF8-dependent secretome reveals novel roles of PHF8 in TLR4-induced acute inflammation and T cell proliferation | Q36835605 | ||
| BET Inhibition Attenuates Helicobacter pylori-Induced Inflammatory Response by Suppressing Inflammatory Gene Transcription and Enhancer Activation. | Q36906022 | ||
| Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX. | Q36936241 | ||
| Promoter-enhancer looping at the PPARγ2 locus during adipogenic differentiation requires the Prmt5 methyltransferase | Q37021516 | ||
| BET proteins promote efficient murine leukemia virus integration at transcription start sites | Q37031911 | ||
| Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling | Q37041173 | ||
| The H3K9 methyltransferase Setdb1 regulates TLR4-mediated inflammatory responses in macrophages | Q37044958 | ||
| H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis. | Q37073091 | ||
| PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB. | Q37103890 | ||
| Pyruvate dehydrogenase kinase regulates hepatitis C virus replication. | Q37137222 | ||
| Antiinflammatory effects of bromodomain and extraterminal domain inhibition in cystic fibrosis lung inflammation | Q37161413 | ||
| Protein arginine methylation facilitates KCNQ channel-PIP2 interaction leading to seizure suppression | Q37201261 | ||
| The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs. | Q39486701 | ||
| Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells | Q39656702 | ||
| Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2. | Q39731654 | ||
| Loss of the Brm-type SWI/SNF chromatin remodeling complex is a strong barrier to the Tat-independent transcriptional elongation of human immunodeficiency virus type 1 transcripts | Q39804456 | ||
| Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit | Q39821089 | ||
| The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription | Q39924470 | ||
| Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation | Q39957980 | ||
| Super enhancers at the miR-146a and miR-155 genes contribute to self-regulation of inflammation | Q40014974 | ||
| Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance. | Q40173008 | ||
| Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe | Q40400270 | ||
| Activating and inhibitory functions for the histone lysine methyltransferase G9a in T helper cell differentiation and function. | Q40463701 | ||
| Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression | Q40521055 | ||
| BRD4 is associated with raccoon polyomavirus genome and mediates viral gene transcription and maintenance of a stem cell state in neuroglial tumour cells | Q40549858 | ||
| DOT1L Activity Promotes Proliferation and Protects Cortical Neural Stem Cells from Activation of ATF4-DDIT3-Mediated ER Stress In Vitro | Q40615754 | ||
| Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis | Q40817673 | ||
| The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC. | Q40837175 | ||
| Control of Paneth Cell Fate, Intestinal Inflammation, and Tumorigenesis by PKCλ/ι. | Q41240523 | ||
| pUL69 of Human Cytomegalovirus Recruits the Cellular Protein Arginine Methyltransferase 6 via a Domain That Is Crucial for mRNA Export and Efficient Viral Replication | Q41583100 | ||
| BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. | Q41641646 | ||
| PRMT1 Upregulated by Epithelial Proinflammatory Cytokines Participates in COX2 Expression in Fibroblasts and Chronic Antigen-Induced Pulmonary Inflammation. | Q41706711 | ||
| NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis | Q41971115 | ||
| Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound. | Q42151914 | ||
| Inhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neurons | Q42175829 | ||
| Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6. | Q42383290 | ||
| Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage. | Q42496540 | ||
| Therapeutic targeting of BET protein BRD4 delays murine lupus | Q42700066 | ||
| Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes | Q42700796 | ||
| Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. | Q42701254 | ||
| Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis | Q42710737 | ||
| Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors | Q42713766 | ||
| S-adenosylhomocysteine induces inflammation through NFkB: A possible role for EZH2 in endothelial cell activation | Q43137066 | ||
| From endoplasmic-reticulum stress to the inflammatory response | Q37225354 | ||
| The endoplasmic reticulum stress response in immunity and autoimmunity | Q37231726 | ||
| Methyltransferase and demethylase profiling studies during brown adipocyte differentiation. | Q37274144 | ||
| Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration | Q37336436 | ||
| Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat. | Q37410634 | ||
| The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance | Q37459848 | ||
| Targeting BET bromodomain proteins in solid tumors | Q37619860 | ||
| S6K1 Phosphorylation of H2B Mediates EZH2 Trimethylation of H3: A Determinant of Early Adipogenesis | Q37666046 | ||
| Epigenetic chemical probes. | Q38055063 | ||
| Lost in transcription: molecular mechanisms that control HIV latency | Q38091888 | ||
| Transcriptional control by NF-κB: elongation in focus | Q38102509 | ||
| Discovery of a PCAF Bromodomain Chemical Probe | Q38434399 | ||
| Immune attack: the role of inflammation in Alzheimer disease. | Q38492631 | ||
| Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence | Q38542092 | ||
| Specific regulation of PRMT1 expression by PIAS1 and RKIP in BEAS-2B epithelia cells and HFL-1 fibroblasts in lung inflammation. | Q38622162 | ||
| Bromodomains: Structure, function and pharmacology of inhibition | Q38680455 | ||
| PRC2 and SWI/SNF Chromatin Remodeling Complexes in Health and Disease | Q38719854 | ||
| Arginine methylation enhances the RNA chaperone activity of the West Nile virus host factor AUF1 p45. | Q38752143 | ||
| BET inhibitors in cancer therapeutics: a patent review | Q38753987 | ||
| BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-кB signaling pathway | Q38760091 | ||
| Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response | Q38785264 | ||
| Histone H3K27 Demethylase JMJD3 in Cooperation with NF-κB Regulates Keratinocyte Wound Healing. | Q38800102 | ||
| PDGF-BB induces PRMT1 expression through ERK1/2 dependent STAT1 activation and regulates remodeling in primary human lung fibroblasts. | Q38800830 | ||
| Glucose-induced expression of the homeotic transcription factor Prep1 is associated with histone post-translational modifications in skeletal muscle | Q38829133 | ||
| BET Inhibition Upregulates SIRT1 and Alleviates Inflammatory Responses | Q38849159 | ||
| Using sequential immunoprecipitation and mass spectrometry to identify methylation of NF-κB. | Q38903969 | ||
| Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway. | Q38909782 | ||
| The Epigenetic Reader BRD2 as a Specific Modulator of PAI-1 Expression in Lipopolysaccharide-Stimulated Mouse Primary Astrocytes | Q38945469 | ||
| KATapulting toward Pluripotency and Cancer | Q38976614 | ||
| Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation | Q38997053 | ||
| Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6. | Q39135199 | ||
| Single-cell dynamics of genome-nuclear lamina interactions | Q39176932 | ||
| Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. | Q39291348 | ||
| UTX-1 regulates Tat-induced HIV-1 transactivation via changing the methylated status of histone H3. | Q39348883 | ||
| Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease | Q33628389 | ||
| Brd2 disruption in mice causes severe obesity without Type 2 diabetes | Q33642463 | ||
| Role of LDB1 in the transition from chromatin looping to transcription activation. | Q33789575 | ||
| Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. | Q33883423 | ||
| Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction | Q33907537 | ||
| BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction. | Q33936571 | ||
| A gain-of-function mouse model identifies PRMT6 as a NF-κB coactivator | Q33983567 | ||
| BET bromodomain inhibition as a novel strategy for reactivation of HIV-1 | Q34032827 | ||
| RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus | Q34064221 | ||
| The art of the chemical probe | Q34098693 | ||
| The cellular bromodomain protein Brd4 has multiple functions in E2-mediated papillomavirus transcription activation | Q34102298 | ||
| Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression | Q34124980 | ||
| (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells | Q34144669 | ||
| Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors | Q34295282 | ||
| A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells | Q34302726 | ||
| BET bromodomain inhibition suppresses TH17-mediated pathology | Q34375887 | ||
| Epigenetic drugs against cancer: an evolving landscape | Q34431964 | ||
| Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. | Q34479551 | ||
| The promise and peril of chemical probes | Q34486195 | ||
| Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. | Q34568110 | ||
| Epigenetic heterogeneity in HIV-1 latency establishment | Q34877762 | ||
| Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis | Q35011877 | ||
| The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) production | Q35126599 | ||
| Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability | Q35150248 | ||
| Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2. | Q35192959 | ||
| Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation | Q35205506 | ||
| Transcriptional activity of the islet β cell factor Pdx1 is augmented by lysine methylation catalyzed by the methyltransferase Set7/9. | Q35352055 | ||
| BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice | Q35533619 | ||
| Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. | Q35549296 | ||
| CXCL8 histone H3 acetylation is dysfunctional in airway smooth muscle in asthma: regulation by BET | Q35574709 | ||
| Repression of hypoxia-inducible factor α signaling by Set7-mediated methylation | Q35610555 | ||
| Histone demethylation maintains Prdm14 and Tsix expression and represses xIst in embryonic stem cells | Q35629117 | ||
| The HIV-1 Tat transactivator protein: a therapeutic target? | Q35652191 | ||
| Transcriptomic Profiling and H3K27me3 Distribution Reveal Both Demethylase-Dependent and Independent Regulation of Developmental Gene Transcription in Cell Differentiation. | Q35742850 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P433 | issue | 5 | |
| P921 | main subject | enzyme | Q8047 |
| nucleoprotein | Q419245 | ||
| transport protein | Q2111029 | ||
| epigenomics | Q3589153 | ||
| small molecule libraries | Q50573438 | ||
| nuclear protein | Q16860021 | ||
| P304 | page(s) | 378-400 | |
| P577 | publication date | 2017-01-12 | |
| 2017-05-04 | |||
| P1433 | published in | Epigenetics | Q15753739 |
| P1476 | title | Chemical probes targeting epigenetic proteins: Applications beyond oncology | |
| P478 | volume | 12 |
| Q92177339 | Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems |
| Q57941480 | Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7 |
| Q47113171 | Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7. |
| Q42070290 | Epigenetic drugs: More than meets the eye. |
| Q88160150 | Epigenetics of Skeletal Diseases |
| Q33755160 | Exploiting Epigenetic Alterations in Prostate Cancer |
Search more.